CD20 is present in 30 to 50 percent of patients with B-cell precursor acute lymphocytic leukemia
(BCP-ALL), a type of leukemia that is common in children but also affects adults.
The rise in awareness programs to treat acute lymphocytic leukemia
patients is one such trend.
For example, HSCT remains an investigational treatment for adults with acute lymphocytic leukemia
because large-scale trials to confirm its effectiveness have not been conducted.
The four indications covered are treatment of acute lymphocytic leukemia
(ALL), chronic lymphocytic leukemia (CLL), acute myelogenous leukemia (AML) and chronic myelogenous leukemia (CML).
The effect of chemotherapy shortage in Iraq during the United Nations (UN) sanctions on outcome of children with acute lymphocytic leukemia
(ALL) [Abstract 3317].
Also, no researchers had adequately compared protracted consolidation/maintenance chemotherapy--the mainstay of treatment for acute lymphocytic leukemia
(ALL)--with autologous transplant to determine efficacy.
Three weeks later, she was readmitted with marked leukocytosis and was found to have acute lymphocytic leukemia
People with acute lymphocytic leukemia
are more likely than healthy people to have the common version of a gene that plays a role in regulating folic acid metabolism in the body, a new study shows.
Recent research has shown significant over-expression of this gene product in a large percentage of patients with leukemia including, chronic and acute myelogenous leukemia and acute lymphocytic leukemia
And for children, though survival rates have climbed, the NCI reports that so have childhood cancer rates from acute lymphocytic leukemia
and cancers of the brain and nervous system.
Global Markets Direct's, 'Acute Lymphocytic Leukemia
(ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2012', provides an overview of the Acute Lymphocytic Leukemia
(ALL, Acute Lymphoblastic Leukemia) therapeutic pipeline.
Two studies present new insights on genetic mutations in children with acute lymphocytic leukemia
(ALL) that indicate higher risk for debilitating chemotherapy-associated bone damage.